Evaluation of Protective Genetic Variants in HIV-1-infected cART Treated Patients
2018-01-01 Lori, Em; Lepri, Ac; Biasin, M; Mercurio, V; Lo Caputo, S; Castelli, F; Castagna, A; Gori, A; Marchetti, G; Venditti, C; Clerici, M; Monforte, Ad
The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
2010-01-01 Stellbrink, Hj; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S
Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy
2012-01-01 Cozzi-Lepri, A; Antinori, A; Magistrelli, E; Castelli, F; Rizzardini, G; Castagna, A; Pellizzer, G; Abrescia, N; Parruti, G; Quirino, T; Castelli, P; Vecchiet, J; Monforte, Ad
Cost-effectiveness evaluation of initial HAART regimens for managing HIV-infected patients according to real clinical practice
2012-01-01 Castagna, A; Colombo, G; Salpietro, S; Galli, L; Poli, A; Lazzarin, A
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area
2015-01-01 Gaiera, G; Chiappetta, S; Carbone, A; Ripa, M; Bigoloni, A; Sala, A; Pozzi, T; Bertocchi, I; Galli, L; Ceserani, N; Poli, A; Castagna, A; Lazzarin, A
CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ
2011-01-01 Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S
REAL-LIFE EXPERIENCE OF DAA-BASED REGIMENS PLUS RIBAVIRIN IN CIRRHOTIC PATIENTS COINFECTED WITH HCV AND HIV-1
2016-01-01 Messina, E; Uberti-Foppa, C; Merli, M; Galli, L; Barbanotti, D; Poli, A; Salpietro, S; Morsica, G; Bagaglio, S; Andolina, A; Castagna, A; Lazzarin, A; Hasson, H
Survival in HIV-1 infected individuals with diagnosis of lymphoma compared to general population: data from ICONA Foundation cohort study
2016-01-01 Cingolani, A; Lepri, Ac; Teofili, L; Galli, L; Mazzotta, V; Baldin, Gm; Hohaus, S; Bandera, A; Alba, L; Galizzi, N; Castagna, A; Monforte, Ad; Antinori, A
Changes in patient-reported outcomes during the SENSE Trial: first-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks
2011-01-01 Alvarez, Cm; Clotet, B; Nelson, M; Uglietti, A; Hill, A; van Delft, Y; Marks, S; Castagna, A.
Prescription pattern and determinants of dolutegravir use in an antiretroviral-naive HIV-infected population in Italy: data from the ICONA Foundation cohort study
2016-01-01 Antinori, A; Lepri, Ac; Castagna, A; Lo Caputo, S; Mussini, C; Rusconi, S; Di Biagio, A; Marchetti, G; Nozza, S; Cingolani, A; De Luca, A; Monforte, Ad
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS
2019-01-01 Clerici, D.; Oltolini, C.; Greco, R.; Pavesi, F.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Lazzari, L.; Scarpellini, P.; Bernardi, M.; Peccatori, J.; Corti, C.; Castagna, A.; Ciceri, F.
PROVIRAL HIV CHANGES CORRELATE WITH CD4+ CD45RA+ T-CELL RECOVERY IN PATIENTS RECEIVING RALTEGRAVIR-INCLUDING REGIMENS
2011-01-01 Gianotti, N.; Malnati, M.; Galli, L.; Galli, A.; Tolazzi, M.; Cassina, G.; Nozza, S.; Della Torre, L.; Castagna, A.; Scarlatti, G.
Patients with HIV-HBV coinfection are an underestimated reservoir for Hepatitis Delta Virus. An analysis of the ICONA cohort
2016-01-01 Gaeta, Gb; Shanyinde, M; Puoti, M; Antonella, Dm; De Luca, A; Castagna, A; Antinori, A; Cozzi-Lepri, A
Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy
2017-01-01 Monforte, Ad; Antinori, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; Castagna, A; Caputo, Sl; Mussini, C; De Luca, A; Madeddu, G; Cingolani, A; Tavelli, A; Taliani, G; Gori, A; Girardi, E; Puoti, M
Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects
2017-01-01 Merli, M; Galli, L; Poli, A; Salpietro, S; Messina, E; Parisi, Mr; Andolina, A; Morsica, G; Bagaglio, S; Castagna, A; Lazzarin, A; Uberti-Foppa, C; Hasson, H
LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY
2011-01-01 Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A
The potential impact of splenectomy in treatment of visceral Leishmaniasis in a multi-experienced HIV-coinfected patient
2017-01-01 Chiappetta, S; Guffanti, M; Cernuschi, M; Bossolasco, S; Maillard, M; Ceserani, N; Boeri, E; Racca, S; Castagna, A; Gaiera, G
Incidence, Temporal Trends, and Predictors of Thrombocytopenia Among HIV-Infected Persons Treated with Combined Antiretroviral Therapy (cART)
2010-01-01 Bibas, M; Trotta, Mp; Lorenzini, P; Cozzi-Lepri, A; Castagna, A; De Luca, A; Mussini, C; Puoti, M; Monforte, Ad; Antinori, A
Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts
2018-01-01 Rossotti, R.; Lorenzini, P.; Merli, M.; Castagna, A.; De Luca, A.; Antinori, A.; Chiamenti, M.; Mastrorosa, I.; Verucchi, G.; Maggiolo, F.; Monforte, A. D.; Puoti, M.
Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine
2010-01-01 Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of Protective Genetic Variants in HIV-1-infected cART Treated Patients | 1-gen-2018 | Lori, Em; Lepri, Ac; Biasin, M; Mercurio, V; Lo Caputo, S; Castelli, F; Castagna, A; Gori, A; Marchetti, G; Venditti, C; Clerici, M; Monforte, Ad | |
| The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients | 1-gen-2010 | Stellbrink, Hj; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S | |
| Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy | 1-gen-2012 | Cozzi-Lepri, A; Antinori, A; Magistrelli, E; Castelli, F; Rizzardini, G; Castagna, A; Pellizzer, G; Abrescia, N; Parruti, G; Quirino, T; Castelli, P; Vecchiet, J; Monforte, Ad | |
| Cost-effectiveness evaluation of initial HAART regimens for managing HIV-infected patients according to real clinical practice | 1-gen-2012 | Castagna, A; Colombo, G; Salpietro, S; Galli, L; Poli, A; Lazzarin, A | |
| Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area | 1-gen-2015 | Gaiera, G; Chiappetta, S; Carbone, A; Ripa, M; Bigoloni, A; Sala, A; Pozzi, T; Bertocchi, I; Galli, L; Ceserani, N; Poli, A; Castagna, A; Lazzarin, A | |
| CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ | 1-gen-2011 | Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S | |
| REAL-LIFE EXPERIENCE OF DAA-BASED REGIMENS PLUS RIBAVIRIN IN CIRRHOTIC PATIENTS COINFECTED WITH HCV AND HIV-1 | 1-gen-2016 | Messina, E; Uberti-Foppa, C; Merli, M; Galli, L; Barbanotti, D; Poli, A; Salpietro, S; Morsica, G; Bagaglio, S; Andolina, A; Castagna, A; Lazzarin, A; Hasson, H | |
| Survival in HIV-1 infected individuals with diagnosis of lymphoma compared to general population: data from ICONA Foundation cohort study | 1-gen-2016 | Cingolani, A; Lepri, Ac; Teofili, L; Galli, L; Mazzotta, V; Baldin, Gm; Hohaus, S; Bandera, A; Alba, L; Galizzi, N; Castagna, A; Monforte, Ad; Antinori, A | |
| Changes in patient-reported outcomes during the SENSE Trial: first-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks | 1-gen-2011 | Alvarez, Cm; Clotet, B; Nelson, M; Uglietti, A; Hill, A; van Delft, Y; Marks, S; Castagna, A. | |
| Prescription pattern and determinants of dolutegravir use in an antiretroviral-naive HIV-infected population in Italy: data from the ICONA Foundation cohort study | 1-gen-2016 | Antinori, A; Lepri, Ac; Castagna, A; Lo Caputo, S; Mussini, C; Rusconi, S; Di Biagio, A; Marchetti, G; Nozza, S; Cingolani, A; De Luca, A; Monforte, Ad | |
| PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS | 1-gen-2019 | Clerici, D.; Oltolini, C.; Greco, R.; Pavesi, F.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Lazzari, L.; Scarpellini, P.; Bernardi, M.; Peccatori, J.; Corti, C.; Castagna, A.; Ciceri, F. | |
| PROVIRAL HIV CHANGES CORRELATE WITH CD4+ CD45RA+ T-CELL RECOVERY IN PATIENTS RECEIVING RALTEGRAVIR-INCLUDING REGIMENS | 1-gen-2011 | Gianotti, N.; Malnati, M.; Galli, L.; Galli, A.; Tolazzi, M.; Cassina, G.; Nozza, S.; Della Torre, L.; Castagna, A.; Scarlatti, G. | |
| Patients with HIV-HBV coinfection are an underestimated reservoir for Hepatitis Delta Virus. An analysis of the ICONA cohort | 1-gen-2016 | Gaeta, Gb; Shanyinde, M; Puoti, M; Antonella, Dm; De Luca, A; Castagna, A; Antinori, A; Cozzi-Lepri, A | |
| Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy | 1-gen-2017 | Monforte, Ad; Antinori, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; Castagna, A; Caputo, Sl; Mussini, C; De Luca, A; Madeddu, G; Cingolani, A; Tavelli, A; Taliani, G; Gori, A; Girardi, E; Puoti, M | |
| Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects | 1-gen-2017 | Merli, M; Galli, L; Poli, A; Salpietro, S; Messina, E; Parisi, Mr; Andolina, A; Morsica, G; Bagaglio, S; Castagna, A; Lazzarin, A; Uberti-Foppa, C; Hasson, H | |
| LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY | 1-gen-2011 | Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A | |
| The potential impact of splenectomy in treatment of visceral Leishmaniasis in a multi-experienced HIV-coinfected patient | 1-gen-2017 | Chiappetta, S; Guffanti, M; Cernuschi, M; Bossolasco, S; Maillard, M; Ceserani, N; Boeri, E; Racca, S; Castagna, A; Gaiera, G | |
| Incidence, Temporal Trends, and Predictors of Thrombocytopenia Among HIV-Infected Persons Treated with Combined Antiretroviral Therapy (cART) | 1-gen-2010 | Bibas, M; Trotta, Mp; Lorenzini, P; Cozzi-Lepri, A; Castagna, A; De Luca, A; Mussini, C; Puoti, M; Monforte, Ad; Antinori, A | |
| Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts | 1-gen-2018 | Rossotti, R.; Lorenzini, P.; Merli, M.; Castagna, A.; De Luca, A.; Antinori, A.; Chiamenti, M.; Mastrorosa, I.; Verucchi, G.; Maggiolo, F.; Monforte, A. D.; Puoti, M. | |
| Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine | 1-gen-2010 | Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista3185
Data di pubblicazione
- In corso di stampa1
- 2020 - 202599
- 2010 - 20191459
- 2000 - 20091289
- 1990 - 1999321
- 1983 - 198916
Editore
- ELSEVIER22
- LIPPINCOTT WILLIAMS & WILKINS14
- NLM (Medline)13
- ELSEVIER SCIENCE BV12
- URBAN & VOGEL12
- ELSEVIER SCIENCE INC11
- DR DIETRICH STEINKOPFF VERLAG10
- OXFORD UNIV PRESS10
- SPRINGER10
- SPRINGER HEIDELBERG10
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS174
- JOURNAL OF NEUROLOGY153
- THE JOURNAL OF UROLOGY152
- BONE MARROW TRANSPLANTATION127
- EUROPEAN NEUROPSYCHOPHARMACOLOGY126
- NEUROLOGICAL SCIENCES88
- BLOOD86
- EUROPEAN HEART JOURNAL72
- NEUROLOGY72
- GASTROENTEROLOGY71
Keyword
- systemic sclerosis12
- Children4
- fibrosis4
- JIA4
- JSLE4
- None4
- angiogenesis3
- animal model3
- Bone mass3
- IPMN3
Lingua
- eng1304
- ita202
- und13
Accesso al fulltext
- no fulltext3152
- reserved25
- open8